GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
187 hedge funds and large institutions have $1.52B invested in Global Blood Therapeutics, Inc. in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 75 increasing their positions, 49 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
33% less capital invested
Capital invested by funds: $2.25B → $1.52B (-$734M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
187
Holding in Top 10
3
Calls
$44.8M
Puts
$8.79M
Top Buyers
| 1 | +$39.8M | |
| 2 | +$20.6M | |
| 3 | +$15.7M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$6.49M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.4M |
Top Sellers
| 1 | -$110M | |
| 2 | -$42.5M | |
| 3 | -$35.5M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$14.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.97M |